NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
$3.02
-0.07 (-2.27%)
At close · Jul 7
Market Cap
$26.28M
Shares
8,702,982
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.02
Open$3.09
Day$3.00–3.11
52W$2.89–6.96
Avg vol 30d30K
Short int42K · 0.5% float · 1.7d
Short vol48%
Last earningsMay 12, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 12
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−33% below
−
Price vs 50-day avg
−21% below
◦
RSI (14)
35 · neutral
+
MACD trend
positive
−
52-week position
3% · near low
Sentiment · smart money
Bearish
◦
Trend (MA cross)
50d $4 › 200d $4 — 200d above 50d
−
Institutional flow
-14% holders QoQ · +7 funds added
−
Insider flow
Net -$31.8K over 90 days · 100% sells
−
Short interest
0.49% of float · ▲ +24.8% MoM · 1.7 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
32 holders — mid 3-yr range
Fundamentals
Excellent
+
Revenue growth
+163% Y/Y
+
Gross margin
57%, expanding
+
EPS growth
+80% Y/Y
−
Free cash flow
$-2.9M
+
Balance sheet
net cash $6.6M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Aug 9, 2026
Est · unconfirmed
· in 5 wks
FQ4-26 quarter ends
~Sep 30, 2026
Est
filed May 12, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−33% below
Bearish
Price vs 50-day avg
−21% below
Bearish
RSI (14)
35 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
3% · near low
Bearish
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $4 › 200d $4 — 200d above 50d
Institutional flow
Distributing
-14% holders QoQ · +7 funds added
Insider flow
Distributing
Net -$31.8K over 90 days · 100% sells
Short interest
Rising
0.49% of float · ▲ +24.8% MoM · 1.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
32 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $3
Now $3 · 3%
52-wk high $7
vs 200-day avg -33%
vs 50-day avg -21%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| cases completed using the OneRF trigeminal nerve ablation system | 16 | Q2 FY2026 call | — |
| product gross margin | 53.8% | Q2 FY2026 call | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NMTC
this stock
NEUROONE MEDICAL TECHNOLOGIES Corp
|
$26.28M | -33.6% | +76.9% | — | 0.5% |
|
ABT
Abbott Laboratories
|
$166.94B | -23.1% | +5.7% | 26.9 | 1.3% |
|
SYK
Stryker Corp
|
$126.41B | -5.9% | +11.2% | 38.2 | 1.6% |
|
MDT
Medtronic plc
|
$107.31B | -12.0% | +8.4% | 22.5 | 1.4% |
|
BSX
Boston Scientific Corp
|
$67.33B | -52.5% | +5.5% | 19.0 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NMTC | -9.6% | -12.2% | -43.6% | -0.7% | -33.6% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | -10.5% | -13.6% | -51.2% | -0.8% | -43.3% |